| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6600ddfc14ad0e0a01fe0746611cbcfd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18 |
| filingDate |
2002-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d555154be28d91ea0cabde0937283c66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab99ea3fee0e00bacfa7e6e69abfc0fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff07b8c2116b4acf9a152e1bdc091672 |
| publicationDate |
2007-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2313363-C2 |
| titleOfInvention |
Hepatitis virus c envelope purified protein for diagnostic and therapeutic application |
| abstract |
FIELD: medicine, virology. n SUBSTANCE: invention relates to therapeutic using of hepatitis virus C purified envelope protein E1. Invention involves using purified recombinant truncated protein E1 HCV 192-326 for preparing a prophylactic composition that in the effective dose is able to induce protection from conversion of acute hepatitis to its chronic form in mammal infected with hepatitis virus C. Protein E1 HCV 192-326 represents a single or oligomeric protein that is not bound with other contaminating proteins by disulfide bond. Advantage of the invention involves detection of prophylactic effectiveness in conversion of acute form to chronic one in protein E1 HCV 192-326 in infection with hepatitis virus C. n EFFECT: valuable medicinal properties of viral protein. n 61 cl, 13 tbl, 18 ex |
| priorityDate |
2001-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |